-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk: The hypoglycemic drug Frehemgo is expected to be launched in Europe in the fourth quarter of 2026 and marketed throughout the European Union in early 2027.

智通财经·09/17/2026 14:17:05
语音播报
Novo Nordisk: The hypoglycemic drug Frehemgo is expected to be launched in Europe in the fourth quarter of 2026 and marketed throughout the European Union in early 2027.